Achillion Pharmaceuticals (ACHN) 11.94 $ACHN
Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for N, CVS, NFLX, PAY and ACHN.
NFLX: 386.22 (+6.82), ACHN: 11.94 (+0.17), CVS: 85.20 (+0.36), N: 105.91 (+2.64), PAY: 36.55 (+1.32)
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
at The Street - Wed Oct 22, 7:39AM CDT
My question about Achillion and ACH-3422 question sparked a robust Twitter debate, which I've reproduced below with some additional comments and explanatory notes.
GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), MRK: 55.85 (-0.60), ABBV: 60.93 (+0.44)
Upcoming Earnings, Presentation of Clinical Data, Dividends, and Technical Updates - Research Reports on Achillion, KB Home, Hovnanian, QEP Resources and Fortune Brands
PR Newswire - Fri Oct 17, 8:30AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), KB Home (NYSE: KBH), Hovnanian Enterprises Inc. (NYSE: HOV), QEP Resources, Inc. (NYSE: QEP) and Fortune Brands Home & Security, Inc. (NYSE: FBHS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7277-100free.
QEP: 24.07 (+0.94), FBHS: 42.56 (+0.57), ACHN: 11.94 (+0.17), KBH: 16.55 (+0.08), HOV: 3.87 (+0.08)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SSRI: 5.57 (+0.31), BRID: 8.58 (+0.08), RENT: 78.40 (+2.54), JAXB: 10.75 (+0.30), RDUS: 20.03 (+0.23), DRIV: 25.69 (+0.20), OBCI: 3.85 (-0.26), SSO.TO: 6.20 (+0.28), ACHN: 11.94 (+0.17), AUXL: 31.91 (+0.33), LAKE: 12.24 (-0.36), GTIV: 19.58 (+0.21)
November 28th Options Now Available For Achillion Pharmaceuticals (ACHN)
DividendChannel.com - Thu Oct 09, 10:04AM CDT
Investors in Achillion Pharmaceuticals Inc. saw new options become available today, for the November 28th expiration.
ACHN: 11.94 (+0.17)
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
GlobeNewswire - Wed Oct 08, 9:23AM CDT
- Late breaker poster presentation will feature updated SVR results from the Phase 2 trial of ACH-3102, NS5A inhibitor, plus sofosbuvir for the eight-week treatment of genotype 1 HCV -
ACHN: 11.94 (+0.17)
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
at The Street - Fri Oct 03, 8:41AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
JNJ: 104.79 (+0.72), SGEN: 36.37 (+0.98), CPRX: 2.72 (+0.08), ACHN: 11.94 (+0.17), SNSS: 1.74 (+0.01), BMY: 54.20 (+0.67)
Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold?
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 01, 11:37AM CDT
Source: Achillion Pharmaceuticals. Achillion investors are probably shaking their heads wondering what's wrong with their company following Johnson & Johnson 's acquisition of the privately held Alios for $1.7 billion this week. On the...
JNJ: 104.79 (+0.72), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17)
J&J Buying Alios, Going Up Against Gilead
at Investor's Business Daily - Tue Sep 30, 11:02AM CDT
Medical giant Johnson & Johnson agreed to buy privately held biotech Alios BioPharma for $1.75 billion Tuesday, advancing its presence in viral diseases. Johnson & Johnson (JNJ) stock was up a fraction in morning trading on the stock market today. In...
JNJ: 104.79 (+0.72), VRTX: 114.07 (+2.48), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), MRK: 55.85 (-0.60)
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
at The Street - Tue Sep 30, 8:49AM CDT
What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?
JNJ: 104.79 (+0.72), VRTX: 114.07 (+2.48), GILD: 113.45 (+0.86), NVAX: 5.48 (-0.32), ACHN: 11.94 (+0.17)
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver
PR Newswire - Tue Sep 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, DWA, SUNE, LOCO and WFM.
WFM: 38.80 (+0.35), SUNE: 19.06 (+0.36), ACHN: 11.94 (+0.17), LOCO: 36.42 (+2.20), DWA: 23.75 (+0.75)
The 5 Best Biotech Stocks in 2014...so far
Todd Campbell, The Motley Fool - Motley Fool - Fri Sep 26, 7:35AM CDT
Since the quarter is wrapping up and investors are considering their game plan heading into year-end, let's look at biotech's biggest winners for the year, why they've rallied, and whether they make sense for your portfolio . Specifically, let's...
GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), RCPT: 95.76 (+28.02), PTCT: 41.30 (+3.67), ICPT: 246.59 (+3.50), PBYI: 252.89 (+7.64)
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma
PR Newswire - Tue Sep 16, 8:05AM CDT
The US markets on Monday, September 15 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,031.14, up 0.26% and the NASDAQ Composite closed at 4,518.90, down 1.07%. The S&P 500 finished the session 0.07% lower at 1,984.13. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 734.33, down 0.32%, whereas the index has gained 6.67% in the previous three months. Investor-Edge has initiated coverage on the following equities: Medivation Inc. (NASDAQ: MDVN), Galectin Therapeutics Inc. (NASDAQ: GALT), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), and PDL BioPharma Inc. (NASDAQ: PDLI). Free research on these five companies can be accessed at:
MDVN: 101.18 (-1.57), IRWD: 13.80 (+0.49), ACHN: 11.94 (+0.17), GALT: 5.21 (+0.27), PDLI: 8.47 (+0.15)
ACHN, IBIO, CRAY, IBCA, QLTY, PIY Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 16, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Ibio Inc (NYSE:IBIO), Cray Inc (NASDAQ:CRAY), Intervest Bancshares Corp (NASDAQ:IBCA), Quality Distribution Inc (NASDAQ:QLTY), Preferredplus Trust Series Czn 1 (NYSE
IY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
PIY: 25.64 (unch), QLTY: 12.84 (+0.71), ACHN: 11.94 (+0.17), IBIO: 1.16 (-0.28), IBCA: 9.74 (+0.02), CRAY: 32.26 (+2.64)
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 242.77 (+21.10), XBI: 171.51 (+4.30), IBB: 293.95 (+3.51), JBLU: 11.38 (+0.30), DEO: 116.04 (+1.32), NOK: 8.43 (+0.06), YHOO: 45.87 (+1.17), EBAY: 51.20 (+0.01), PLCE: 48.35 (+0.58), TWTR: 43.78 (-4.78), MSFT: 46.49 (+0.58), AAPL: 106.74 (+1.63), REGN: 397.89 (-9.27), AMZN: 295.59 (+5.62), ABX: 13.52 (+0.22), NADL: 5.64 (+0.14), DRI: 52.03 (+0.61), CELG: 105.70 (+2.60), AA: 16.60 (+0.22), BIDU: 228.96 (+9.04), TSO: 67.44 (+1.61), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), IWM: 114.17 (+3.16), BF.B: 90.95 (+1.44), CRM: 61.53 (+2.42)
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver
PR Newswire - Mon Sep 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, LITB, VJET, WFM and DIS.
WFM: 38.80 (+0.35), VJET: 14.04 (+1.03), ACHN: 11.94 (+0.17), DIS: 89.93 (+1.48), LITB: 6.51 (+0.28)
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
at The Street - Thu Sep 11, 6:47PM CDT
As long as it's here, good things are happening every day, Cramer says.
SD: 3.96 (+0.20), RH: 78.26 (+1.37), RAX: 37.49 (+0.92), EMN: 76.55 (+2.21), OKE: 59.88 (-0.53), KORS: 78.17 (+1.48), ATK: 129.77 (+2.15), CNVR: 35.33 (+0.51), SBUX: 77.05 (+1.08), SON: 40.34 (+0.33), ACAD: 27.89 (+0.85), COH: 34.00 (-2.15), FSLR: 57.38 (+3.09), ISIS: 46.43 (+0.57), ACHN: 11.94 (+0.17), JE: 4.76 (-0.06), MTN: 86.55 (+2.11), AIG: 52.84 (+1.10), KATE: 26.82 (+0.48), TWTR: 43.78 (-4.78), TASR: 16.28 (+0.65), SWHC: 10.20 (+0.27)
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:58AM CDT
Can the Rally in Achillion (ACHN) Shares Continue?
ACHN: 11.94 (+0.17)
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications
PR Newswire - Tue Sep 09, 7:35AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Deere & Company (NYSE: DE), Honeywell International Inc. (NYSE: HON), Lockheed Martin Corporation (NYSE: LMT) and L-3 Communications Holdings Inc. (NYSE: LLL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6311-100free.
LMT: 185.55 (+2.55), HON: 95.17 (+1.47), ACHN: 11.94 (+0.17), DE: 85.49 (+0.91), LLL: 116.76 (+1.53)
Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for N, CVS, NFLX, PAY and ACHN.
NFLX: 386.22 (+6.82), ACHN: 11.94 (+0.17), CVS: 85.20 (+0.36), N: 105.91 (+2.64), PAY: 36.55 (+1.32)
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
at The Street - Wed Oct 22, 7:39AM CDT
My question about Achillion and ACH-3422 question sparked a robust Twitter debate, which I've reproduced below with some additional comments and explanatory notes.
GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), MRK: 55.85 (-0.60), ABBV: 60.93 (+0.44)
Upcoming Earnings, Presentation of Clinical Data, Dividends, and Technical Updates - Research Reports on Achillion, KB Home, Hovnanian, QEP Resources and Fortune Brands
PR Newswire - Fri Oct 17, 8:30AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), KB Home (NYSE: KBH), Hovnanian Enterprises Inc. (NYSE: HOV), QEP Resources, Inc. (NYSE: QEP) and Fortune Brands Home & Security, Inc. (NYSE: FBHS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7277-100free.
QEP: 24.07 (+0.94), FBHS: 42.56 (+0.57), ACHN: 11.94 (+0.17), KBH: 16.55 (+0.08), HOV: 3.87 (+0.08)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SSRI: 5.57 (+0.31), BRID: 8.58 (+0.08), RENT: 78.40 (+2.54), JAXB: 10.75 (+0.30), RDUS: 20.03 (+0.23), DRIV: 25.69 (+0.20), OBCI: 3.85 (-0.26), SSO.TO: 6.20 (+0.28), ACHN: 11.94 (+0.17), AUXL: 31.91 (+0.33), LAKE: 12.24 (-0.36), GTIV: 19.58 (+0.21)
November 28th Options Now Available For Achillion Pharmaceuticals (ACHN)
DividendChannel.com - Thu Oct 09, 10:04AM CDT
Investors in Achillion Pharmaceuticals Inc. saw new options become available today, for the November 28th expiration.
ACHN: 11.94 (+0.17)
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
GlobeNewswire - Wed Oct 08, 9:23AM CDT
- Late breaker poster presentation will feature updated SVR results from the Phase 2 trial of ACH-3102, NS5A inhibitor, plus sofosbuvir for the eight-week treatment of genotype 1 HCV -
ACHN: 11.94 (+0.17)
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
at The Street - Fri Oct 03, 8:41AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
JNJ: 104.79 (+0.72), SGEN: 36.37 (+0.98), CPRX: 2.72 (+0.08), ACHN: 11.94 (+0.17), SNSS: 1.74 (+0.01), BMY: 54.20 (+0.67)
Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold?
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 01, 11:37AM CDT
Source: Achillion Pharmaceuticals. Achillion investors are probably shaking their heads wondering what's wrong with their company following Johnson & Johnson 's acquisition of the privately held Alios for $1.7 billion this week. On the...
JNJ: 104.79 (+0.72), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17)
J&J Buying Alios, Going Up Against Gilead
at Investor's Business Daily - Tue Sep 30, 11:02AM CDT
Medical giant Johnson & Johnson agreed to buy privately held biotech Alios BioPharma for $1.75 billion Tuesday, advancing its presence in viral diseases. Johnson & Johnson (JNJ) stock was up a fraction in morning trading on the stock market today. In...
JNJ: 104.79 (+0.72), VRTX: 114.07 (+2.48), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), MRK: 55.85 (-0.60)
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
at The Street - Tue Sep 30, 8:49AM CDT
What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?
JNJ: 104.79 (+0.72), VRTX: 114.07 (+2.48), GILD: 113.45 (+0.86), NVAX: 5.48 (-0.32), ACHN: 11.94 (+0.17)
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver
PR Newswire - Tue Sep 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, DWA, SUNE, LOCO and WFM.
WFM: 38.80 (+0.35), SUNE: 19.06 (+0.36), ACHN: 11.94 (+0.17), LOCO: 36.42 (+2.20), DWA: 23.75 (+0.75)
The 5 Best Biotech Stocks in 2014...so far
Todd Campbell, The Motley Fool - Motley Fool - Fri Sep 26, 7:35AM CDT
Since the quarter is wrapping up and investors are considering their game plan heading into year-end, let's look at biotech's biggest winners for the year, why they've rallied, and whether they make sense for your portfolio . Specifically, let's...
GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), RCPT: 95.76 (+28.02), PTCT: 41.30 (+3.67), ICPT: 246.59 (+3.50), PBYI: 252.89 (+7.64)
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma
PR Newswire - Tue Sep 16, 8:05AM CDT
The US markets on Monday, September 15 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,031.14, up 0.26% and the NASDAQ Composite closed at 4,518.90, down 1.07%. The S&P 500 finished the session 0.07% lower at 1,984.13. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 734.33, down 0.32%, whereas the index has gained 6.67% in the previous three months. Investor-Edge has initiated coverage on the following equities: Medivation Inc. (NASDAQ: MDVN), Galectin Therapeutics Inc. (NASDAQ: GALT), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), and PDL BioPharma Inc. (NASDAQ: PDLI). Free research on these five companies can be accessed at:
MDVN: 101.18 (-1.57), IRWD: 13.80 (+0.49), ACHN: 11.94 (+0.17), GALT: 5.21 (+0.27), PDLI: 8.47 (+0.15)
ACHN, IBIO, CRAY, IBCA, QLTY, PIY Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 16, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Ibio Inc (NYSE:IBIO), Cray Inc (NASDAQ:CRAY), Intervest Bancshares Corp (NASDAQ:IBCA), Quality Distribution Inc (NASDAQ:QLTY), Preferredplus Trust Series Czn 1 (NYSE
IY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: PIY: 25.64 (unch), QLTY: 12.84 (+0.71), ACHN: 11.94 (+0.17), IBIO: 1.16 (-0.28), IBCA: 9.74 (+0.02), CRAY: 32.26 (+2.64)
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 242.77 (+21.10), XBI: 171.51 (+4.30), IBB: 293.95 (+3.51), JBLU: 11.38 (+0.30), DEO: 116.04 (+1.32), NOK: 8.43 (+0.06), YHOO: 45.87 (+1.17), EBAY: 51.20 (+0.01), PLCE: 48.35 (+0.58), TWTR: 43.78 (-4.78), MSFT: 46.49 (+0.58), AAPL: 106.74 (+1.63), REGN: 397.89 (-9.27), AMZN: 295.59 (+5.62), ABX: 13.52 (+0.22), NADL: 5.64 (+0.14), DRI: 52.03 (+0.61), CELG: 105.70 (+2.60), AA: 16.60 (+0.22), BIDU: 228.96 (+9.04), TSO: 67.44 (+1.61), GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), IWM: 114.17 (+3.16), BF.B: 90.95 (+1.44), CRM: 61.53 (+2.42)
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver
PR Newswire - Mon Sep 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, LITB, VJET, WFM and DIS.
WFM: 38.80 (+0.35), VJET: 14.04 (+1.03), ACHN: 11.94 (+0.17), DIS: 89.93 (+1.48), LITB: 6.51 (+0.28)
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
at The Street - Thu Sep 11, 6:47PM CDT
As long as it's here, good things are happening every day, Cramer says.
SD: 3.96 (+0.20), RH: 78.26 (+1.37), RAX: 37.49 (+0.92), EMN: 76.55 (+2.21), OKE: 59.88 (-0.53), KORS: 78.17 (+1.48), ATK: 129.77 (+2.15), CNVR: 35.33 (+0.51), SBUX: 77.05 (+1.08), SON: 40.34 (+0.33), ACAD: 27.89 (+0.85), COH: 34.00 (-2.15), FSLR: 57.38 (+3.09), ISIS: 46.43 (+0.57), ACHN: 11.94 (+0.17), JE: 4.76 (-0.06), MTN: 86.55 (+2.11), AIG: 52.84 (+1.10), KATE: 26.82 (+0.48), TWTR: 43.78 (-4.78), TASR: 16.28 (+0.65), SWHC: 10.20 (+0.27)
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:58AM CDT
Can the Rally in Achillion (ACHN) Shares Continue?
ACHN: 11.94 (+0.17)
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications
PR Newswire - Tue Sep 09, 7:35AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Deere & Company (NYSE: DE), Honeywell International Inc. (NYSE: HON), Lockheed Martin Corporation (NYSE: LMT) and L-3 Communications Holdings Inc. (NYSE: LLL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6311-100free.
LMT: 185.55 (+2.55), HON: 95.17 (+1.47), ACHN: 11.94 (+0.17), DE: 85.49 (+0.91), LLL: 116.76 (+1.53)
